Clinical vertebral fractures following denosumab discontinuation. [electronic resource]
- Endocrine Oct 2016
- 271-272 p. digital
Publication Type: Case Reports; Letter
1559-0100
10.1007/s12020-016-1030-6 doi
Bone Density Conservation Agents--therapeutic use Denosumab--therapeutic use Female Humans Middle Aged Osteoporosis--complications Osteoporotic Fractures--etiology Spinal Fractures--etiology Withholding Treatment